Grossi Federico 4
4 · Apellis Pharmaceuticals, Inc. · Filed Sep 2, 2022
Insider Transaction Report
Form 4
Grossi Federico
See Remarks
Transactions
- Sale
Common Stock
2022-09-01$60.30/sh−2,500$150,750→ 104,884 total
Footnotes (1)
- [F1]This is a scheduled sale from 10b5-1 trading plan.